Bioplus Life Sciences

Bengaluru, India Founded: 2004 • Age: 22 yrs Minicorn
Novel therapeutics and pharmaceutical products are developed and manufactured.

About Bioplus Life Sciences

Bioplus Life Sciences is a Healthcare company based in Bengaluru (India) founded in 2004 by Sundeep Aurora. Novel therapeutics and pharmaceutical products are developed and manufactured. It operates on a Professional Services and HealthTech model. Bioplus Life Sciences has raised $29.37 million across 1 funding round from investors including AIF Capital. The company has 553 employees. Bioplus Life Sciences was last valued at $321.18 million in June 2008. Its chief executive, as recorded, is Sundeep Aurora. Its Indian entity Bioplus Life Sciences Private Limited reported revenue of β‚Ή143 Cr. Bioplus Life Sciences offers products and services including 7-MX and Nutraceutical Products. Its focus areas include Pharmaceuticals and Ophthalmology Drugs.

Company details

Bioplus Life Sciences is focused on the development of innovative therapeutics for global unmet medical needs, particularly in ophthalmology. The company is involved in research and development of novel drugs like 7-MX for pediatric myopia control. Additionally, solutions are provided in nutraceuticals and dietary supplements. Operations span across clinical and pre-clinical stages, with a presence in over 50 countries. Advanced technology and extensive research are utilized to enhance product and service quality in the healthcare sector.

  • Headquarters Bengaluru, India
  • Employees 553
  • Founders Sundeep Aurora
  • Stage Minicorn
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bioplus.in
  • Social LinkedIn X Facebook
  • Legal Name Bioplus Life Sciences
  • Date of Incorporation 19 Mar, 2004
  • Jurisdiction Bangalore, Karnataka, India
Key Metrics
  • Annual Revenue
    ₹143 Cr

    FY 2025 · +46% YoY

  • Net Profit
    ₹26.44 Cr

    FY 2025 · 9% margin

  • EBITDA
    ₹37.32 Cr

    FY 2025 · 13% margin

  • Total Equity Funding
    $29.37M (USD)

    in 1 rounds

  • Latest Funding Round
    $29.37M (USD), Series B

    Jun 2008

  • Investors
  • Employee Count
    553

Products & Services of Bioplus Life Sciences

Bioplus Life Sciences offers a comprehensive portfolio of products and services, including 7-MX and Nutraceutical Products.

7-MX
Ophthalmology Drug

Developed for pediatric myopia control as therapeutic solution.

Nutraceutical Products
Dietary Supplements

Formulated to support health through innovative food ingredients.

Funding Insights of Bioplus Life Sciences

Bioplus Life Sciences has successfully raised a total of $29.37M through 1 strategic funding round. The most recent funding activity was a Series B round of $29.37 million completed in June 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $29.37M
  • Total Rounds 1
  • Last Round Series B β€” $29.37M
  • First Round $29.37M

    (Jun 2008)

  • Investors Count 1

All 1 funding rounds of Bioplus Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2008$29.37MSeries B$321.18MAIF Capital
–
Valuation history
DateValuationStage
Jun 2008$321.18Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $321.18M (Jun 2008). 1 investors in total: 1 institutional.

Investors in Bioplus Life Sciences

Bioplus Life Sciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include AIF Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Investment funding and expertise for emerging businesses in Asia.
1994aifcapital.com
Premium access

Investor details for Bioplus Life Sciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Bioplus Life Sciences Private Limited (Bioplus Life Sciences)

Bioplus Life Sciences Private Limited is the primary company behind Bioplus Life Sciences. The board of Bioplus Life Sciences Private Limited currently have 4 directors; the longest-serving is Sundeep Aurora, appointed in 2008. 11 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sundeep Aurora
DIN 02244640
Director12 May 200818 yrs 6 moBioplus Life Sciences Private Limited
Sunjeev Aurora
DIN 02244616
Director12 May 200818 yrs 6 moBioplus Life Sciences Private Limited
Neha Aurora
DIN 07283383
Additional Director29 Oct 20251 yrBioplus Life Sciences Private Limited
Rhea Ishani Aurora
DIN 11351935
Additional Director29 Oct 20251 yrBioplus Life Sciences Private Limited

People of Bioplus Life Sciences

2 people are tracked at Bioplus Life Sciences (2 in leadership); the tracked headcount is 553.

NameRoleGroup
Founder & CEOLeadership
Vice President & CFOLeadership
Premium access

Complete people profiles for Bioplus Life Sciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Bioplus Life Sciences

Figures of Bioplus Life Sciences Private Limited, the primary company behind Bioplus Life Sciences, for FY 2025. Revenue was ₹143 Cr (+46% year on year). Net profit was ₹26.44 Cr (9% margin). EBITDA was ₹37.32 Cr (13% margin). Revenue has grown at a compounded annual rate of +30% over three years and +12% over five years.

  • ₹143 CrRevenue · FY 2025 · +46% YoY
  • ₹26.44 CrNet profit · 9% margin
  • ₹37.32 CrEBITDA · 13% margin
  • ₹3.00 CrPaid-up capital
  • 276Employees (provident fund records)
  • +30%Revenue CAGR, 3 years
  • +12%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Bioplus Life Sciences Private Limited are on its company page.

Premium access

Detailed financial statements for Bioplus Life Sciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Bioplus Life Sciences

3 dated milestones of Bioplus Life Sciences across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Bioplus Life Sciences is founded.
  2. Funding First funding round of $29.4M.
  3. Milestone Reaches Minicorn status.

Web traffic of Bioplus Life Sciences

The website of Bioplus Life Sciences (bioplus.in) receives about 5.9K visits a month and ranks #8,003,749 among all websites worldwide, #7,219 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    5.9K

    ▲ 230.7% vs previous month

  • Global rank
    #8,003,749

    among all websites

  • Category rank
    #7,219

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Bioplus Life Sciences. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bioplusrx.com
100%
21.6K#1,353,684View details
srico-labworld.com
srico-labworld.com
63%
#12,069,669–
biochain.in
biochain.in
60%
#8,779,875–

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Bioplus Life Sciences (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Oral solid drug delivery systems are manufactured and developed.
1985Mumbai, Maharashtra, IndiaUSD 42.49 MUSD 72.52 M1,115
Generic, semi-solid, and liquid dosage forms are manufactured.
1990Bengaluru, Karnataka, IndiaUSD 508.93 M4,050
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983Mumbai, Maharashtra, IndiaUSD 6.44 B19,801
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bioplus Life Sciences

Premium access

Complete news archive for Bioplus Life Sciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bioplus Life Sciences

Bioplus Life Sciences was founded in 2004 and raised its 1st funding round 4 years after it was founded.

Bioplus Life Sciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Sundeep Aurora is the CEO of Bioplus Life Sciences, as recorded in our data. They have also founded this company.

Bioplus Life Sciences is a funded company, having raised a total of $29.37M across 1 funding round to date. The company's 1st funding round was a Series B of $29.37M, raised on Jun 2008.

Bioplus Life Sciences has 553 employees.

The primary company behind Bioplus Life Sciences, Bioplus Life Sciences Private Limited, reported revenue of β‚Ή143 Cr for FY 2025, up 46% year on year.

Bioplus Life Sciences is focused on the development of innovative therapeutics for global unmet medical needs, particularly in ophthalmology. The company is involved in research and development of novel drugs like 7-MX for pediatric myopia control. Additionally, solutions are provided in nutraceuticals and dietary supplements. Operations span across clinical and pre-clinical stages, with a presence in over 50 countries. Advanced technology and extensive research are utilized to enhance product and service quality in the healthcare sector.

Bioplus Life Sciences offers 7-MX and Nutraceutical Products.

Bioplus Life Sciences has 1 investor. Key investors include AIF Capital.

The valuation of Bioplus Life Sciences is $321.18M as of Jun 2008.

Bioplus Life Sciences operates through Bioplus Life Sciences Private Limited.

The legal entities of Bioplus Life Sciences currently have 4 directors, including Neha Aurora, Sundeep Aurora, Sunjeev Aurora and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available